NCT02688894View on ClinicalTrials.gov

The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

RecruitingOBSERVATIONAL
Enrollment

797

Participants

Timeline

Start Date

April 29, 2016

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
Small Cell Lung CancersNeuroendocrine Carcinoma
Interventions
OTHER

No treatment is included in this protocol.

"Tumor tissues (fresh or archival) will be analyzed using NGS-based cancer panel, nanostring CNV, immunohistochemistry and/or FISH.~Specific methods of each molecular tests will be defined with standard laboratory manual developed by pathologists."

Trial Locations (6)

Unknown

COMPLETED

Gachon University Gil Medical Center, Incheon

COMPLETED

Chungbuk University Hospital, Jungbuk

COMPLETED

Seoul National University Bundang Hospital, Seongnam

COMPLETED

VHS Medical Center, Seoul

COMPLETED

Ulsan University Hospital, Ulsan

135-710

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT02688894 - The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S] | Biotech Hunter | Biotech Hunter